Y-mAbs Therapeutics Inc. (YMAB)
NASDAQ: YMAB
· Real-Time Price · USD
3.92
0.06 (1.55%)
At close: May 16, 2025, 10:47 AM
Y-mAbs Therapeutics Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for YMAB stock have an median target of 20, with a low estimate of 7 and a high estimate of 26. The median target predicts an increase of 410.20% from the current stock price of 3.92.
Latest Analyst Insight Report
Truist Securities maintains a Buy rating on Y-mAbs... Unlock content with Pro Subscription
Updated May 14, 2025
Financial Forecast this Year
Revenue This Year
83.1M
from 87.69M
Increased by -5.2%
Revenue Next Year
95.38M
from 83.1M
Increased by 14.8%
EPS This Year
-1.02
from -0.67
Increased by -52.2%
EPS Next Year
-1.09
from -1.02
Increased by -6.9%